Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Opioid-Related Disorders; Substance-Related Disorders

Treatments: Drug: LAAM

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000356

Y01-3-0012-5

NIDA-3-0012-5

Details and patient eligibility

About

The purpose of this study is to determine the pharmacokinetics of L-alpha-acetylmethadol (LAAM) in adults transferred from methadone maintenance treatment for opiate dependence.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.